The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.60
Bid: 100.20
Ask: 101.60
Change: -0.20 (-0.20%)
Spread: 1.40 (1.397%)
Open: 100.80
High: 104.20
Low: 100.20
Prev. Close: 101.80
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Jun 2016 07:00

RNS Number : 6604A
PZ CUSSONS PLC
09 June 2016
 

9 June 2016

 PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc, a leading consumer products group, today issues the following trading update for the year ended 31 May 2016.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group for the year ended 31 May 2016 has been in line with expectations with performance in Europe and Asia offsetting more difficult trading conditions in Africa.

The financial position of the Group remains strong with cash generation also in line with expectations.

 

Trading Update

 

Europe

 

In the UK washing and bathing division, all brands have performed strongly driven by a continuous programme of renovation and innovation. The Imperial Leather portfolio has been extended with a new range of Sweets and Fruits products for bath and shower. The new range of shower and bath products under the Carex brand has performed well in addition to good growth across the core range of handwash products. Original Source has also performed well with new fragrances launched across its range of shower, handwash and body care products.

 

In the beauty division, St Tropez has seen excellent growth its key markets of UK, US and Australia. The gradual tan in shower lotion launched last year has been particularly successful and the range has recently been extended with a darker variant. Further product launches have also taken place across the Sanctuary, Charles Worthington and Fudge brands.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, good performance across Personal Care, Beauty and Food & Nutrition has offset more difficult trading conditions in the Home Care category. Both five:am and Rafferty's Garden have extended their product portfolios during the year with Rafferty's Garden launching into chilled products and continuing its overseas expansion into selected geographies.

 

Indonesia has seen another year of good revenue growth with the entire baby range being completely re-launched in the second half of the year. Further renovation has also taken place across Imperial Leather, Carex and Original Source.

 

Overall performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, all business units are selling relatively well despite a challenging macro environment where consumers are being affected by inflationary pressures. We continue to have market leading brand shares across Personal Care, Home Care, Electricals and Food & Nutrition and product offerings at all price points. In addition, our nationwide distribution and heritage in Nigeria are serving us well in these difficult trading conditions.

 

There continues to be low levels of dollar liquidity in the economy with an additional cost of funding naira from the secondary market. Our focus is on securing materials for the key selling product lines, developing local sourcing to reduce our overall dollar requirements and ensuring relative pricing remains competitive.

 

Overall performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Exceptional Charge

 

An exceptional charge of circa £17m is expected in relation to settling a brought forward dollar liability in Nigeria in the secondary market. The charge will be accounted for as it is realised with circa £7m being taken in the year to 31 May 2016.

 

Outlook

 

Performance in Europe and Asia is expected to be strong driven by the continuing brand renovation and innovation programme underpinned by strong cost control.

 

In Nigeria, which represents approximately 25% of group profits, trading conditions are expected to continue to be challenging, with a range of potential outcomes for the new financial year dependent on the translational and transactional impacts of any movement in the naira exchange rate. The Group remains well placed to benefit from its position in Nigeria once growth returns to the market.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities for growth as they arise.

 

Final results

 

Final results for the year ended 31 May 2016 will be announced on Tuesday 26 July 2016.

 

An analysts' presentation will be given at 9:30am on that day. This will be held at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Dial in details will be available immediately following the final results announcement.

 

- ENDS -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Tim Linacre

Guy Scarborough

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWRNRNVANRAR
Date   Source Headline
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.